THK (6481) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
18 Mar, 2026Executive summary
Consolidated revenue for the first half of fiscal 2025 decreased by 2.0% year-over-year to ¥176.2 billion, with industrial machinery showing recovery but automotive and transportation remaining flat.
Operating income dropped 26.4% year-over-year to ¥6.1 billion, impacted by cost hikes, sales mix, and a stronger yen.
Profit attributable to owners of the parent declined 48.3% to ¥3.7 billion, affected by structural reform costs and increased U.S. import tariffs.
Revenue exceeded the initial plan by ¥2.9 billion, but operating income fell short by ¥0.8 billion due to higher U.S. import tariffs.
Comprehensive loss for the period was ¥9,364 million, compared to a comprehensive income of ¥42,305 million a year earlier.
Financial highlights
Revenue increased in China, Asia, and other regions, but decreased in Japan, the Americas, and Europe year-over-year.
Operating income margin declined to 3.5% from 4.7% year-over-year.
Total assets decreased to ¥515.5 billion from ¥567.4 billion at the previous year-end.
Equity attributable to owners of the parent dropped to ¥323.1 billion, with a significant decrease in foreign currency translation reserve.
Cash and cash equivalents declined by ¥36.8 billion to ¥101.5 billion as of June 30, 2025.
Outlook and guidance
Full-year 2025 revenue forecast is ¥363.5 billion (+3.0% year-over-year), with operating income projected at ¥23.5 billion and profit attributable to owners of the parent at ¥18.0 billion.
Profit per share for the year is forecast at ¥148.14.
Management maintains the fiscal 2025 plan, expecting to offset U.S. tariff impacts by reviewing sales prices and cost reductions.
No changes have been made to previously announced forecasts.
Initiatives to achieve ROE over 10% are underway, targeting fiscal 2027–2029 for realization.
Latest events from THK
- Major loss from business transfer drives net loss, but strong FY2026 recovery forecast.6481
Q4 202518 Mar 2026 - Revenue was stable but profit fell; FY2025 outlook expects strong profit recovery.6481
Q4 202418 Mar 2026 - Revenue and profit fell year-over-year, but recovery and new product initiatives support outlook.6481
Q2 202418 Mar 2026 - Profit plunged despite stable revenue, but full-year outlook and dividend were raised.6481
Q1 202518 Mar 2026 - Profit and revenue fell year-over-year, with margin pressure and cautious full-year outlook.6481
Q3 202418 Mar 2026 - Revenue up, but profits down sharply on higher costs and equity-method losses.6481
Q3 202511 Nov 2025